BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24383847)

  • 1. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
    Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
    Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adhesive properties of eosinophils in sickle cell disease.
    Canalli AA; Conran N; Fattori A; Saad ST; Costa FF
    Exp Hematol; 2004 Aug; 32(8):728-34. PubMed ID: 15308324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
    Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
    Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
    Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
    Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
    Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
    J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.
    Assis A; Conran N; Canalli AA; Lorand-Metze I; Saad ST; Costa FF
    Acta Haematol; 2005; 113(2):130-6. PubMed ID: 15802892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.
    Lintomen L; Franchi G; Nowill A; Condino-Neto A; de Nucci G; Zanesco A; Antunes E
    BMC Pulm Med; 2008 Aug; 8():13. PubMed ID: 18700028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
    El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cells.
    Verger E; Schoëvaërt D; Carrivain P; Victor JM; Lapouméroulie C; Elion J
    Clin Hemorheol Microcirc; 2014; 57(1):9-22. PubMed ID: 24002118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
    Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
    Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
    Styles LA; Lubin B; Vichinsky E; Lawrence S; Hua M; Test S; Kuypers F
    Blood; 1997 Apr; 89(7):2554-9. PubMed ID: 9116302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.
    Chaar V; Laurance S; Lapoumeroulie C; Cochet S; De Grandis M; Colin Y; Elion J; Le Van Kim C; El Nemer W
    J Biol Chem; 2014 Apr; 289(16):11512-11521. PubMed ID: 24616094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease.
    Laurance S; Pellay FX; Dossou-Yovo OP; Verger E; Krishnamoorthy R; Lapoumeroulie C; Benecke A; Elion J
    Pharmacogenet Genomics; 2010 Apr; 20(4):257-68. PubMed ID: 20216336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
    Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
    J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Ribeiro PR; Teixeira RDS; Souza AR; Pereira TCS; Boffo EF; Carosio MGA; Ferreira AG; Oliveira RV; Rodrigues LEA; Silva JJ; de Souza AJ; Ladeia AMT
    Br J Haematol; 2021 Mar; 192(5):922-931. PubMed ID: 33476407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
    Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
    Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
    Silva DG; Belini Junior E; Torres Lde S; Ricci Júnior O; Lobo Cde C; Bonini-Domingos CR; de Almeida EA
    Blood Cells Mol Dis; 2011 Jun; 47(1):23-8. PubMed ID: 21489839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.